Follow the 씨어스 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 씨어스 has logged 14 public disclosures. Market capitalisation: €858.2bn. The latest transaction was disclosed on 1 April 2026 (Purchase). Among the most active insiders: 윈베스트벤처투자. Every trade is accessible without an account.
14
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,589 of 29,062 companies
60.1
score / 100
Value
29
Quality
92
FCF yld0.1%
Earn yld1.9%
EV/EBITDA48.8x
ROE80%
Gross mgn72%
Net mgn33%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.